Description: "This session explores the impact of climate change on mortality trends, drawing insights from a South African study that examines the relationship between rising temperatures, extreme weather events, and excess deaths. We will discuss the key findings, statistical methods used (including copulas for dependency modeling), and the broader implications for insurers, reinsurers, and policymakers. The session will also touch on how climate risk is increasingly shaping actuarial assumptions, pricing, and capital management. By the end of this session, participants will: - Understand the relationship between climate change and mortality trends, with a focus on South African data. - Explore statistical methodologies, including copula modeling, to assess dependencies between temperature and excess deaths. - Assess the implications of climate-related mortality risks for life insurance and reinsurance. - Identify potential adaptations in underwriting, pricing, and capital management to account for climate risk."

Description: As the adoption of offshore reinsurance strategies continues to grow among insurers seeking to optimize their capital and balance sheets, a critical focus for both prospective and current adopters is the establishment or enhancement of existing data, technology, and modeling processes to meet offshore reporting requirements. Drawing from practical experience, this presentation aims to provide attendees with key insights for successfully producing the necessary reporting items for offshore reinsurance entities, along with considerations for operational efficiency, model and data governance, and management decision-making.

Description: Discover the multitude of risk transfer solutions and payment models available to health claims payers for cell & gene therapies in this Society of Actuaries webinar. Delving deeper into the topic, we will examine the different types of solutions, weigh their pros and cons, and explore the future prospects of this rapidly evolving area of the healthcare landscape. By expanding upon the pricing and risk exposure discussion from session two, this webinar provides valuable insights into the dynamic market for cell & gene therapies and its implications for actuaries.

Description: Explore historical trends in enrollment, carrier participation, and competition over the first 10 years of the individual marketplace as a basis to frame what the future could hold for the next 10 years. Draw parallels to other lines of business (e.g., Medicare Advantage, employer group) as we look at how the market may evolve and the capabilities required to succeed. This session would be valuable for anyone interested in consumer purchasing behavior, quality and risk adjustment, employer benefits, provider dynamics, and the individual market more broadly. By attending this this session, you will be able to articulate the impact of recent legislation and regulatory actions on the Individual market, including subsidies, employer funding vehicles (e.g., ICHRA), distribution channels, and product requirements.

Description: For this session, we will explore difference in Medicare products from Traditional Medicare to Medicare Advantage. It will clarify different parts of the benefits and the role of Medigap plans. We will then discuss the impending changes in Medicare Part D due to the Inflation Reduction Act, highlighting redesigned benefits, stakeholder impacts, & potential risks. This informative session aims to demystify Medicare, providing insights into existing structures and forthcoming alterations.

Description: Management service organizations (MSOs) in value-based care have expanded into far more locations in the health care ecosystem; some demonstrate value to both buyers and providers. Explore the role of these players in the health care ecosystem, their future outlook, and how actuaries can help them perform.

Description: Insurance companies are substantially transforming their finance operating model. This is mainly trigged by the prevailing changes in the insurance regulatory landscape that are leaning towards principle-based reporting and valuation, which is leading to a significant increase in the effort needed for regulatory and management reporting.

Description: An attorney and a statistician will discuss the latest on GenAI, the AI regulation and litigation affecting the use of AI in insurance.

Description: Meet the authors of and learn about the contributors to the newly published e-book "Design Your Future with the Competency Framework." Presenters will share their personal reflections, stories and words of wisdom to bring to life the eight professional and personal competencies in the SOA Competency Framework.

Description: Develop a better understanding of specialty drug trends and their increasing healthcare costs for more than the past decade by attending this webcast. With the introduction of price competition, you will see changes in the market for biosimilar products and patent-protected drugs. For example, the drug Humira will be gaining 10 biosimilar competitors in 2023. Alone, Humira can represent over 20% of total pharmacy spend for health plans. Join us and discover how price competition is a turning point for the pharmaceutical industry and will define its direction for the next decade.